In pancreatic ductal adenocarcinoma, Simon et al. (2024) revealed that CDH2 was a specific target of SMAD1; by encoding N-cadherin it can promote migration ability in malignant cells. This evidence concerns the gene SMAD1 and pancreatic ductal adenocarcinoma.